Literature DB >> 18715664

Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients.

Alicia Jenkins1, Sarah X Zhang, Albina Gosmanova, Christopher Aston, Azar Dashti, Mary Zoe Baker, Timothy Lyons, Jian-Xing Ma.   

Abstract

Serum PEDF levels (mean (S.D.)) were increased in 96 Type 2 diabetic vs. 54 non-diabetic subjects; 5.3 (2.8) vs. 3.2 (2.0)mug/ml, p<0.001. In diabetes, PEDF correlated with BMI, serum creatinine and LDL-cholesterol, but not with other lipids, HbA1c or CRP. PEDF did not differ by drugs, complications, or gender.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18715664      PMCID： PMC2597065          DOI： 10.1016/j.diabres.2008.06.019

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  10 in total

Review 1.  PEDF: a multifaceted neurotrophic factor.

Authors:  Joyce Tombran-Tink; Colin J Barnstable
Journal:  Nat Rev Neurosci       Date:  2003-08       Impact factor: 34.870

2.  Increased serum concentrations of pigment epithelium-derived factor in patients with end-stage renal disease.

Authors:  Yoshihiro Motomiya; Sho-Ichi Yamagishi; Hisashi Adachi; Akio Abe
Journal:  Clin Chem       Date:  2006-10       Impact factor: 8.327

3.  Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy.

Authors:  Joshua J Wang; Sarah X Zhang; Kangmo Lu; Ying Chen; Robert Mott; Sanai Sato; Jian-Xing Ma
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

4.  Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor.

Authors:  Sarah X Zhang; Joshua J Wang; Guoquan Gao; Chunkui Shao; Robert Mott; Jian-xing Ma
Journal:  FASEB J       Date:  2005-12-20       Impact factor: 5.191

5.  Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.

Authors:  Joshua J Wang; Sarah X Zhang; Robert Mott; Ryan R Knapp; Wei Cao; Kai Lau; Jian-Xing Ma
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

6.  Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy.

Authors:  Nahoko Ogata; Masato Matsuoka; Kayako Matsuyama; Chieko Shima; Aran Tajika; Toshiyuki Nishiyama; Mitsumasa Wada; Nobuo Jo; Akiko Higuchi; Keizo Minamino; Hiroshi Matsunaga; Toshihiko Takeda; Miyo Matsumura
Journal:  J Clin Endocrinol Metab       Date:  2007-01-09       Impact factor: 5.958

7.  Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.

Authors:  Sarah X Zhang; Joshua J Wang; Guoquan Gao; Kyoungmin Parke; Jian-xing Ma
Journal:  J Mol Endocrinol       Date:  2006-08       Impact factor: 5.098

8.  Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.

Authors:  A J Jenkins; S X Zhang; K G Rowley; C S Karschimkus; C L Nelson; J S Chung; D N O'Neal; A S Januszewski; K D Croft; T A Mori; G Dragicevic; C A Harper; J D Best; T J Lyons; J-X Ma
Journal:  Diabet Med       Date:  2007-10-29       Impact factor: 4.359

9.  [Change and significance of serum pigment epithelium-derived factor in type 2 diabetic nephropathy].

Authors:  Hai-bing Chen; Wei-ping Jia; Jun-xi Lu; Yu-qian Bao; Qing Li; Feng-di Lu; Wei Lu; Hao-yong Yu; Kun-San Xiang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2007-05-15

10.  Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome.

Authors:  Sho-Ichi Yamagishi; Hisashi Adachi; Akio Abe; Takako Yashiro; Mika Enomoto; Kumiko Furuki; Asuka Hino; Yuko Jinnouchi; Katsuhiko Takenaka; Takanori Matsui; Kazuo Nakamura; Tsutomu Imaizumi
Journal:  J Clin Endocrinol Metab       Date:  2006-03-07       Impact factor: 5.958
  10 in total
  30 in total

1.  Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients.

Authors:  Alicia J Jenkins; Dongxu Fu; Madona Azar; Julie A Stoner; Derrick G Kaufman; Sarah Zhang; Richard L Klein; Maria F Lopes-Virella; Jian-Xing Ma; Timothy J Lyons
Journal:  J Diabetes Complications       Date:  2014-01-17       Impact factor: 2.852

2.  Effect of a 12-month exercise intervention on serum biomarkers of angiogenesis in postmenopausal women: a randomized controlled trial.

Authors:  Catherine Duggan; Liren Xiao; Ching-Yun Wang; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-05       Impact factor: 4.254

Review 3.  Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.

Authors:  Elizabeth P Moran; Zhongxiao Wang; Jing Chen; Przemyslaw Sapieha; Lois E H Smith; Jian-Xing Ma
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-29       Impact factor: 4.733

4.  Pigment epithelium-derived factor (PEDF) varies with body composition and insulin resistance in healthy young people.

Authors:  Kyle L Sunderland; Jeanie B Tryggestad; Joshua J Wang; April M Teague; Lauren V Pratt; Sarah X Zhang; David M Thompson; Kevin R Short
Journal:  J Clin Endocrinol Metab       Date:  2012-08-28       Impact factor: 5.958

5.  Elevated plasma pigment epithelium-derived factor in children with type 2 diabetes mellitus is attributable to obesity.

Authors:  Jeanie B Tryggestad; Joshua J Wang; Sarah X Zhang; David M Thompson; Kevin R Short
Journal:  Pediatr Diabetes       Date:  2014-10-08       Impact factor: 4.866

6.  Identification of pigment epithelium-derived factor as an adipocyte-derived inflammatory factor.

Authors:  Sangeeta S Chavan; LaQueta K Hudson; Jian Hua Li; Mahendar Ochani; Yael Harris; Nirav B Patel; David Katz; Joshua A Scheinerman; Valentin A Pavlov; Kevin J Tracey
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

Review 7.  Pulmonary vascular dysfunction in metabolic syndrome.

Authors:  Conor Willson; Makiko Watanabe; Atsumi Tsuji-Hosokawa; Ayako Makino
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

8.  Molecular targets for diabetes mellitus-associated erectile dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; Moses T Tar; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

9.  Emetine Di-HCl Attenuates Type 1 Diabetes Mellitus in Mice.

Authors:  LaQueta K Hudson; Meghan E Dancho; Jianhua Li; Johanna B Bruchfeld; Ahmed A Ragab; Mingzhu M He; Meaghan Bragg; Delaney Lenaghan; Michael D Quinn; Jason R Fritz; Matthew V Tanzi; Harold A Silverman; William M Hanes; Yaakov A Levine; Valentin A Pavlov; Peder S Olofsson; Jesse Roth; Yousef Al-Abed; Ulf Andersson; Kevin J Tracey; Sangeeta S Chavan
Journal:  Mol Med       Date:  2016-06-10       Impact factor: 6.354

Review 10.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.